Cargando…
[Rectacted] miR‑106b‑5p promotes cell cycle progression of malignant melanoma by targeting PTEN
Autores principales: | Chen, Xu-E, Chen, Pu, Chen, Shan-Shan, Ma, Ting, Shi, Guang, Zhou, Ya, Li, Ji, Sheng, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696543/ https://www.ncbi.nlm.nih.gov/pubmed/37997815 http://dx.doi.org/10.3892/or.2023.8669 |
Ejemplares similares
-
MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer
por: Li, Nana, et al.
Publicado: (2017) -
Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
Publicado: (2018) -
Retracted: miR-204-5p Hampers Breast Cancer Malignancy and Affects the Cell Cycle by Targeting PRR11
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Retraction Note: Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML
por: Zhao, Lifen, et al.
Publicado: (2020) -
miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN
por: Liu, Kai, et al.
Publicado: (2022)